Talk:Immunoglobulin therapy
The contents of the Hyperimmune globulin page were merged into Immunoglobulin therapy on 15 May 2021. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
This is not a forum for general discussion of the article's subject.
- Put new text under old text. Click here to start a new topic.
- New to Wikipedia? Welcome! Learn to edit; get help.
- Assume good faith
- Be polite and avoid personal attacks
- Be welcoming to newcomers
- Seek dispute resolution if needed
It is of interest to the following WikiProjects:
This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks. | ||
Mid | This article has been rated as Mid-importance on the project's importance scale. |
WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine. | This article is within the scope of||
Mid | This article has been rated as Mid-importance on the project's importance scale. |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Immunoglobulin therapy.
|
Repeated additions of passive immunity as the mechanism of action
[edit]This edit, like another recent one that I reverted, seems to conflate immunoglobulin therapy with passive immunity. While passive immunity is one of the potential benefits of immunoglobulin therapy, as noted in the "Medical Uses" section there are other effects and indications - so the language strongly tying this therapy with passive immunity is incorrect and inconsistent with the body of the article (something that the lede should not do). I'm not sure the article needs to say more about passive immunization than it already does, based on reliable sources. — soupvector (talk) 04:13, 25 December 2015 (UTC)
- I've added a sentence to the lede - hope it helps address the perceived gap. — soupvector (talk) 04:18, 25 December 2015 (UTC)
Anaphylaxis
[edit]Role of IgA disputed doi:10.1111/trf.12796 JFW | T@lk 13:14, 16 August 2019 (UTC)
Split
[edit]The general idea of Immunoglobulin therapy is not limited to the injection of normal human Immunoglobulin. NHIG should be split out as a drug article, so the Ig therapy page can discuss different preparations of Igs used on humans, including the proposed merge from Hyperimmune globulin (Talk:Hyperimmune_globulin#Merger_discussion). --Artoria2e5 🌉 13:24, 16 December 2020 (UTC)